Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients

NCT02639143 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Inflammation
Thrombosis

Interventions

DRUG: ticagrelor
DRUG: Clopidogrel

Sponsor

First Affiliated Hospital of Harbin Medical University